The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1164
September 1, 2003
View Complete Issue         Table of Contents 2019 
Testim and Striant - Two New Testosterone Products
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Testim and Striant - Two New Testosterone Products
September 1, 2003 (Issue: 1164)
Two new topical testosterone products, a 1% gel (Testim) and a buccal tablet (Striant), have been approved by the FDA for treatment of hypogonadism in men. This review briefly describes hypogonadism and its causes and lists other available...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Testim and Striant - Two New Testosterone Products
Article code: 1164b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.